Beacon Biosignals
About Beacon Biosignals
Beacon Biosignals is a neuroscience-focused company developing AI-powered neurotechnology to advance brain health, with platforms and services that support clinical trials and drug development. The company specializes in EEG-based biomarkers and quantitative sleep endpoints, enabling at-home sleep EEG capture, low-latency event monitoring, and full-service clinical study operations to extract meaningful insights across neurological and psychiatric indications. Headquartered around the United States and serving the clinical research ecosystem, Beacon combines data science with clinical expertise to accelerate trials and inform labeling claims for CNS disorders.
Recent News
No recent news for this company.